These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 10090437

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of three statins at lower maintenance doses.
    Carr-Lopez S, Exstrum T, Morse T, Shepherd M, Bush AC.
    Clin Ther; 1999 Feb; 21(2):331-9. PubMed ID: 10211536
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
    Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR.
    Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Is there a relationship between early statin compliance and a reduction in healthcare utilization?
    Aubert RE, Yao J, Xia F, Garavaglia SB.
    Am J Manag Care; 2010 Jun; 16(6):459-66. PubMed ID: 20560689
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A, Proietti I, Altamura L, Tomai F, Versaci F, Crea F, Chiariello L, Gioffrè PA.
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of statins.
    Huse DM, Russell MW, Miller JD, Kraemer DF, D'Agostino RB, Ellison RC, Hartz SC.
    Am J Cardiol; 1998 Dec 01; 82(11):1357-63. PubMed ID: 9856919
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG, Bayne WF.
    Biol Mass Spectrom; 1993 Jan 01; 22(1):1-8. PubMed ID: 8431499
    [Abstract] [Full Text] [Related]

  • 37. Pravastatin versus simvastatin for prevention of contrast-induced nephropathy.
    Muñoz MA, Maxwell PR, Green K, Hughes DW, Talbert RL.
    J Cardiovasc Pharmacol Ther; 2011 Jan 01; 16(3-4):376-9. PubMed ID: 21386035
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Does higher usage of low-cost statins correlate with a poorer achievement in cholesterol quality markers for secondary prevention?
    Hickman J.
    Br J Gen Pract; 2010 Jan 01; 60(570):50-2. PubMed ID: 20040169
    [Abstract] [Full Text] [Related]

  • 40. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
    Alford JC, Saseen JJ, Allen RR, Nair KV.
    Pharmacotherapy; 2012 Jul 01; 32(7):623-30. PubMed ID: 22570173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.